首页> 外文会议>Hemophilie-Symposion >Inactiwatlon of Animal Factor VIII by human Factor VIII Inhibitors: Inwestigation of Plasma from Patients with Inhibitors in congenital Hemophilia I and from Patients with acquired Hemophilia A
【24h】

Inactiwatlon of Animal Factor VIII by human Factor VIII Inhibitors: Inwestigation of Plasma from Patients with Inhibitors in congenital Hemophilia I and from Patients with acquired Hemophilia A

机译:人为因子VIII抑制剂的动物因子VIII的乙酰丁酮:先天性血友病药中抑制剂患者的血浆中的预防

获取原文

摘要

In a number of patients with congenital Hemophilia A the treatment is complicated by the presence of factor VIII inhibitors. These are alloantibodies which the patients only develop after receiving replacement therapy with factor VIII preparations.Spontaneous factor VIII inhibitors, on the other hand, are antibodies to factor VIII which occur as a result of an autoimmune reaction in individuals with previously normal coagulation and lead to a usually severe acquired factor VIII deficiency with the associated clinical consequences. This disorder is known as spontaneous or acquired hemophilia A [1,2,5-7,10,13-17].
机译:在许多先天性血友病患者中,通过因子VIII抑制剂存在,治疗复杂。这些是患者仅在接受因子VIII制剂的替代治疗后发生的患者。另一方面,抑制剂是对因子VIII的抗体,这是由于具有先前正常凝血的个体的自身免疫反应而发生的因子VIII。一种通常严重的获得因子VIII缺乏相关的临床后果。这种疾病被称为自发性或获得的血友病A [1,2,5-7,10,13-17]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号